Management strategies in patients with statin-associated muscle symptoms: What is the best strategy?

J Clin Lipidol. 2016 Sep-Oct;10(5):1067-72. doi: 10.1016/j.jacl.2016.06.008. Epub 2016 Jun 25.

Authors

Tisha R Joy¹, Emily T Brennan²

Affiliations

¹ Division of Endocrinology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic address: tisjoy@hotmail.com.
² Division of Endocrinology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

PMID: 27678422
DOI: 10.1016/j.jacl.2016.06.008

No abstract available

Publication types

Editorial

MeSH terms

Dose-Response Relationship, Drug
Drug Substitution / methods*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Lipid Metabolism / drug effects*
Medication Therapy Management
Muscular Diseases / etiology*
Muscular Diseases / prevention & control

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors